Similarly, medical studies report that new GLP-1 prescriptions have become predominantly for obesity rather than diabetes: e.g., in 20192023 only ~57% of new GLP-1 patients had T2D (down from ~65% a decade earlier) ( [27] ) ( [28] )
For acute or anticipated pain, such as after a surgical procedure, taking the medications before the pain peaks is more effective than trying to catch up later
PlexusDx clinicians review 14 peptide pathways and 150+ genetic insights to rule out confounding factors
And since they can target multiple signaling pathways simultaneously, dual agonist drugs may also lead to improved metabolic action
Diabetic Ketoacidosis (DKA): Not indicated for individuals with type 1 diabetes or diabetic ketoacidosis
Marston oversees both Ozempic MDLs The consolidated Ozempic lawsuits are pending in the Eastern District of Pennsylvania Ozempic is primarily prescribed for Type 2 diabetes management Some doctors prescribe Ozempic off-label for weight loss Trials in MDLs are scheduled for late 2026 and early 2027, but these dates may change